Zhejiang

300357.SZ

Tags: CN Healthcare Drug Manufacturers - General

Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. Price (300357.SZ)

Stock Price

Low: Year Low

High: Year High

Market Cap

Fetching Data...

Enterprise Value

Fetching Data...

Shares Outstanding

523,607,157

(0.0044)%

Market Cap of Zhejiang (300357.SZ)

Market cap:

As of , 300357.SZ has a market cap of . This makes 300357.SZ the 1179th most valuable company in the CN by market cap. Market capitalization, or market cap, is the total value of a company's outstanding shares of stock, calculated by multiplying the current stock price by the total number of shares.

Year

Beginning Of Year

End Of Year

YOY Change

Revenue and Profitability

Year	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Revenue	37,407,159	59,327,652	103,176,299	147,517,280	193,609,754	239,511,105	267,105,585	312,085,773	385,576,841	500,744,692	639,352,853	636,208,242	807,691,606	896,016,141	848,190,443
Net Income	10,513,193	18,405,879	37,264,729	53,773,772	70,564,349	99,554,760	117,820,024	129,200,974	186,103,945	232,884,097	298,296,581	278,447,284	337,991,284	348,773,471	310,184,878
FCF USD	-8,850,736	3,975,845	15,156,213	33,920,343	40,774,913	61,037,463	83,309,124	86,843,669	124,407,657	148,702,501	133,096,523	186,064,297	238,418,431	171,541,260	172,916,189
OCF USD	12,628,500	14,537,871	19,149,703	41,166,426	58,303,540	83,703,086	114,820,239	122,772,455	159,134,139	206,452,525	232,925,579	256,221,705	360,575,120	360,279,064	382,075,662

Financial Health - DEBT

Year	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
YTPD	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.01	0.04	0.07
D/E	0.00	0.11	0.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.01	0.00	0.01	0.03
CA/CL	14.89	3.50	5.61	16.93	16.21	27.58	19.66	14.79	15.56	13.57	17.49	21.13	12.42	14.38	8.87
TA/TL	12.79	5.50	7.52	19.64	21.93	29.93	21.40	16.87	18.03	16.93	18.73	20.95	14.27	12.87	9.91
Total Debt	0	10,000,000	10,000,000	0	0	0	0	0	0	0	0	9,809,267	7,806,236	16,262,710	55,647,875

Management Performance

Year	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
ROIC	9.01%	15.95%	24.90%	27.95%	27.53%	18.27%	19.42%	20.10%	22.80%	23.04%	21.24%	17.35%	17.88%	15.92%	12.18%
ROE	9.40%	20.36%	29.21%	29.65%	28.01%	19.39%	20.21%	19.71%	23.23%	24.02%	23.47%	19.13%	19.47%	17.62%	14.20%
ROA	0.00%	16.65%	25.32%	28.14%	26.73%	18.74%	19.27%	18.54%	21.94%	21.92%	20.49%	16.81%	16.89%	15.27%	11.53%
NM %	28.10%	31.02%	36.12%	36.45%	36.45%	41.57%	44.11%	41.40%	48.27%	46.51%	46.66%	43.77%	41.85%	38.92%	36.57%
FCF / R%	0.00%	6.70%	14.69%	22.99%	21.06%	25.48%	31.19%	27.83%	32.27%	29.70%	20.82%	29.25%	29.52%	19.14%	20.39%
FCF / NI%	-84.19%	21.60%	40.67%	63.08%	57.79%	61.31%	70.71%	67.22%	66.85%	64.13%	45.48%	68.98%	73.07%	51.10%	58.51%
Operating Margin (OM)	0.00	0.05	0.33	0.56	0.75	0.60	0.76	0.84	1.01	1.06	0.77	1.02	1.10	1.22	1.49

Per Share

Year	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
EPS	0.02	0.04	0.08	0.12	0.15	0.19	0.23	0.25	0.36	0.44	0.57	0.53	0.65	0.67	0.59
SPS	0.08	0.13	0.22	0.32	0.41	0.46	0.51	0.60	0.74	0.96	1.22	1.22	1.54	1.71	1.62
OCPS	0.03	0.03	0.04	0.09	0.12	0.16	0.22	0.23	0.30	0.39	0.44	0.49	0.69	0.69	0.73
FCPS	-0.02	0.01	0.03	0.07	0.09	0.12	0.16	0.17	0.24	0.28	0.25	0.36	0.46	0.33	0.33
BVPS	0.24	0.19	0.27	0.39	0.54	0.99	1.11	1.25	1.53	1.90	2.58	2.92	3.43	3.87	4.40

Per Share - CAGR

Year	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
CAGR-EPS	0.02	0.04	0.08	0.12	0.15	0.19	0.23	0.25	0.36	0.44	0.57	0.53	0.65	0.67	0.59
CAGR-SPS	0.08	0.13	0.22	0.32	0.41	0.46	0.51	0.60	0.74	0.96	1.22	1.22	1.54	1.71	1.62
CAGR-OCPS	0.03	0.03	0.04	0.09	0.12	0.16	0.22	0.23	0.30	0.39	0.44	0.49	0.69	0.69	0.73
CAGR-FCPS	-0.02	0.01	0.03	0.07	0.09	0.12	0.16	0.17	0.24	0.28	0.25	0.36	0.46	0.33	0.33
CAGR-BVPS	0.24	0.19	0.27	0.39	0.54	0.99	1.11	1.25	1.53	1.90	2.58	2.92	3.43	3.87	4.40

Revenue $848.19M

-5.34%

10Y

Net Income $310.18M

-11.06%

10Y

Operating Cash Flow $382.08M

+6.05%

10Y

Free Cash Flow $172.92M

+0.80%

10Y

YTPD $0.07

+96.60%

10Y

D/E $0.03

+210.00%

10Y

CA/CL $8.87

-38.32%

10Y

TA/TL $9.91

-22.98%

10Y

ROIC $12.18%

-23.51%

10Y

ROE $14.20%

-19.43%

10Y

ROA $11.53%

-24.49%

10Y

Net Margin $36.57%

-6.05%

10Y

FCF / R% $20.39%

+6.49%

10Y

FCFNI % $58.51%

+14.51%

10Y

Operating Margin $1.49

+22.06%

10Y

EPS $0.59

-11.07%

10Y

SPS $1.62

-5.34%

10Y

OCPS $0.73

+6.05%

10Y

FCPS $0.33

+0.80%

10Y

BVPS $4.40

+13.64%

10Y

Wordpress Tutorials

eCommerce Website Tutorials

Responsive Design

Zhejiang

Stock Price

Fetching Data...

Fetching Data...

Fetching Data...

523,607,157

Market Cap of Zhejiang (300357.SZ)

Market cap:

Year

Beginning Of Year

End Of Year

YOY Change

Revenue of Zhejiang (300357.SZ)

Revenue:

Year

Revenue

YOY Change

Net Income of Zhejiang (300357.SZ)

Net Income:

Year

Net Income

YOY Change

Free Cash Flow of Zhejiang (300357.SZ)

Free Cash Flow:

Year

FreeCash flow

YOY Change

Operating Cash Flow of Zhejiang (300357.SZ)

Operating Cash Flow:

Year

Operating Cashflow

YOY Change

Return on Invested capital of Zhejiang (300357.SZ)

Return on Invested capital: %

%

Year

Return on Invested Capital

YOY Change

Return on Equity of Zhejiang (300357.SZ)

Return on Equity: %

%

Year

Return on Equity

YOY Change

Return on Assets of Zhejiang (300357.SZ)

Return on Assets: %

%

Year

ROA

YOY Change

Total debt of Zhejiang (300357.SZ)

Total debt:

Year

MarketCap

YOY Change

Marketing Budget of Zhejiang (300357.SZ)

Marketing Budget:

Year

MarketCap

YOY Change

Employee of Zhejiang (300357.SZ)

Employee:

Year

Employees Number

YOY Change

Payroll of Zhejiang (300357.SZ)

Payroll:

Year

Payroll

YOY Change

Dividends of Zhejiang (300357.SZ)

Dividends:

Year

Dividends

YOY Change

Executive Compensation of Zhejiang (300357.SZ)

Executive Compensation: